Marinus Historical Income Statement
| MRNS Stock | USD 0.33 0.01 3.13% |
Historical analysis of Marinus Pharmaceuticals income statement accounts such as Total Revenue of 32.5 M can show how well Marinus Pharmaceuticals performed in making a profits. Evaluating Marinus Pharmaceuticals income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Marinus Pharmaceuticals's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Marinus Pharmaceuticals latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Marinus Pharmaceuticals is a good buy for the upcoming year.
Marinus |
About Marinus Income Statement Analysis
Marinus Pharmaceuticals Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Marinus Pharmaceuticals shareholders. The income statement also shows Marinus investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Marinus Pharmaceuticals Income Statement Chart
Add Fundamental
Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Marinus Pharmaceuticals. It is also known as Marinus Pharmaceuticals overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Total Operating Expenses
The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.Most accounts from Marinus Pharmaceuticals' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Marinus Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Marinus Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For more information on how to buy Marinus Stock please use our How to Invest in Marinus Pharmaceuticals guide.At this time, Marinus Pharmaceuticals' Interest Income is comparatively stable compared to the past year.
Marinus Pharmaceuticals income statement Correlations
Click cells to compare fundamentals
Marinus Pharmaceuticals Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Marinus Pharmaceuticals income statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Depreciation And Amortization | 171.9K | 334K | 667K | 669K | 551K | 578.6K | |
| Selling General Administrative | 11.5M | 18.5M | 37.3M | 56.8M | 60.5M | 63.5M | |
| Gross Profit | (503K) | 1.7M | 13.9M | 25.1M | 29.1M | 30.5M | |
| Other Operating Expenses | 54.4M | 69.7M | 112.3M | 138.3M | 162.5M | 170.6M | |
| Operating Income | (54.4M) | (67.9M) | (96.9M) | (112.8M) | (131.5M) | (124.9M) | |
| Ebit | (54.3M) | (67.9M) | (96.2M) | (5.8M) | (126.0M) | (119.7M) | |
| Research Development | 43.0M | 51.1M | 73.5M | 79.9M | 99.4M | 104.4M | |
| Ebitda | (54.1M) | (67.6M) | (95.5M) | (5.1M) | (125.5M) | (119.2M) | |
| Cost Of Revenue | 503K | 50.5M | 1.5M | 340K | 1.9M | 1.8M | |
| Total Operating Expenses | 54.4M | 69.7M | 110.8M | 137.9M | 160.5M | 168.6M | |
| Income Before Tax | (54.1M) | (67.5M) | (98.8M) | (16.4M) | (142.9M) | (135.8M) | |
| Total Other Income Expense Net | 301K | 462K | (1.8M) | 96.4M | (11.5M) | (10.9M) | |
| Net Income | (53.8M) | (66.6M) | (101.7M) | (19.8M) | (141.4M) | (134.3M) | |
| Income Tax Expense | (354K) | (833K) | 2.9M | 3.4M | (1.5M) | (1.5M) | |
| Net Income From Continuing Ops | (54.1M) | (67.5M) | (98.8M) | (19.8M) | (133.9M) | (127.3M) | |
| Non Operating Income Net Other | 301K | 462K | 80K | (342K) | (307.8K) | (292.4K) | |
| Net Income Applicable To Common Shares | (54.1M) | (76.4M) | (98.8M) | (19.8M) | (17.8M) | (18.7M) | |
| Interest Income | 354K | 499K | 80K | 2.4M | 8.1M | 8.5M | |
| Net Interest Income | 354K | 499K | (2.5M) | (8.3M) | (8.2M) | (7.8M) | |
| Reconciled Depreciation | 278K | 334K | 355K | 418K | 508K | 337.2K |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Marinus Stock Analysis
When running Marinus Pharmaceuticals' price analysis, check to measure Marinus Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Marinus Pharmaceuticals is operating at the current time. Most of Marinus Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Marinus Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Marinus Pharmaceuticals' price. Additionally, you may evaluate how the addition of Marinus Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.